Side Effects of Risperdal
Justice for Victims of Risperdal Side Effects
The pharmaceutical giant Johnson & Johnson has recently been ordered to pay $2.2 billion in health care fraud settlements due to illegal marketing tactics of the drugs Risperdal, Invega and Natrecor. Ortho-McNeil-Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, pled guilty to charges that sales reps illegally promoted Risperdal to physicians as an effective treatment for elderly patients experiencing anxiety, agitation, depression, hostility and confusion. Civil lawsuits concerning the side effects of Risperdal and male breast growth are escalating, however.
The controversial drug, approved by the FDA in 1994 for the treatment of schizophrenia, bi-polar mania and autistic disorder irritability, made headlines when a Pennsylvania man alleged that he developed abnormal breast tissue as a result of taking Risperdal for five years. Other lawsuits concerning similar side effects of Risperdal were filed in Louisiana, South Carolina and Texas, resulting in settlements ranging from $158 million to $327 million.
A 2006 study published in the Journal of Clinical Psychopharmacology was one of the first to indicate the link between Risperdal and breast development in boys, a condition known as gynecomastia. According to the study, Risperdal strongly increases the production of prolactin, a hormone that stimulates breast development in women. Young, developing boys are at high risk of developing gynecomastia, which may require surgical procedures to remedy.
Hundreds of lawsuits across the U.S. are being filed against Johnson & Johnson for failing to properly warn physicians and patients about the risk of male breast growth. If this has happened to you or a loved one, justice is a phone call away. Our lawyers are currently filing claims on behalf of victims who are suffering from Risperdal side effects. Call now for a free consultation: 1-800-THE-LAW2.
Other Side Effects of Risperdal
Ortho-McNeil-Janssen Pharmaceuticals recently recalled Risperdal in 3mg and 2mg doses due to reports of an uncharacteristic odor possibly associated with trace amounts of TBA, a chemical preservative. Released into the market in 2010 and 2011, Ortho-McNeil-Janssen believes that there are approximately 1,600 bottles of 3mg and 2mg Risperdal still in the marketplace.
The FDA first approved the drug in 1994. Since then, a number of reports concerning the side effects of Risperdal have been released, including two FDA Safety Alerts in 2011 warning users of the following adverse effects:
- Metabolic changes, such as hyperglycemia, dyslipidemia and weight gain, which have been associated with increased cardiovascular/cerebrovascular risk
- Blood and lymphatic system disorders, such as neutropenia
- Nervous system disorders
- Increases in blood cholesterol and blood triglyceride levels
Risperdal has also been associated with increased risk of:
- Pituitary tumors
- Suicidal thoughts
- Bone loss
- Tardive Dyskinesia
- Neuroleptic Malignant Syndrome (NMS)
Whether you’re suffering from male breast growth or the Risperdal side effects mentioned above, you need a lawyer to ensure that you get compensation for your pain and suffering. Call 1-800-THE-LAW2 to get the legal help you need: 1-800-THE-LAW2.
Compassionate Help, 24/7
1-800-THE-LAW2 has helped thousands of people get qualified legal representation since 1985. Our representatives are available 24 hours a day, 365 days a year to help you get connected with an experienced, affordable lawyer right away.
If you’re suffering from the side effects of Risperdal, you deserve justice. For a FREE Risperdal male breast growth lawsuit evaluation, call us at 1-800-THE-LAW2.